MEDI4893* Promotes Survival and Extends the Antibiotic Treatment Window in a Staphylococcus aureus Immunocompromised Pneumonia Model
about
How Can Vaccines Contribute to Solving the Antimicrobial Resistance Problem?Investigational drugs to treat methicillin-resistant Staphylococcus aureusStaphylococcus aureus in the Intensive Care Unit: Are These Golden Grapes Ripe for a New Approach?Context matters: The importance of dimerization-induced conformation of the LukGH leukocidin of Staphylococcus aureus for the generation of neutralizing antibodies.Phenol-Soluble Modulins Contribute to Early Sepsis Dissemination Not Late Local USA300-Osteomyelitis Severity in Rabbits.Beyond Antibiotics: New Therapeutic Approaches for Bacterial Infections.Staphylococcus aureus Alpha-Toxin Is Conserved among Diverse Hospital Respiratory Isolates Collected from a Global Surveillance Study and Is Neutralized by Monoclonal Antibody MEDI4893Improved Protection in a Rabbit Model of Community-Associated Methicillin-Resistant Staphylococcus aureus Necrotizing Pneumonia upon Neutralization of Leukocidins in Addition to Alpha-Hemolysin.Prevention and treatment of Staphylococcus aureus biofilms.Chemical and Biological Aspects of Nutritional Immunity - Perspectives for New Anti-infectives Targeting Iron Uptake Systems.Pediatric Multiple Organ Dysfunction Syndrome: Promising Therapies.Investigational drugs in phase I and phase II clincial trials for the treatment of hospital-acquired pneumonia.Virulence factor targeting of the bacterial pathogen Staphylococcus aureus for vaccine and therapeutics.In Situ Capture of Bacterial Toxins for Antivirulence Vaccination.Targeting Alpha Toxin To Mitigate Its Lethal Toxicity in Ferret and Rabbit Models of Staphylococcus aureus Necrotizing Pneumonia.MEDI3902 correlates of protection against severe Pseudomonas aeruginosa pneumonia in a rabbit acute pneumonia model.Deciphering the Pathological Role of Staphylococcal α-Toxin and Panton-Valentine Leukocidin Using a Novel Ex Vivo Human Skin Model.Staphylococcus aureus toxin antibodies: Good companions of antibiotics and vaccines.
P2860
Q26748155-72F91CCA-BF62-4EF8-8432-886CF7B6FFA5Q26780246-289E0B8B-4772-4910-B484-C934A6A559FEQ30239977-565CC604-2737-47BC-AF7D-9A4937BF6710Q36088381-306EF9CE-A754-45A5-9AD3-077CB977F4FBQ36982947-43F99A23-8FD4-4C48-8E12-57D651C58501Q36991788-CE6E2193-86F8-4FE3-A77A-20DFC7096896Q37203734-44D71C78-5330-496B-80D9-07DF1EA24EBEQ37287867-079A9936-D876-4E17-9AA6-10828CC4804CQ37482155-1BD3BEF0-933A-4635-A4DB-AC4362265195Q38691254-3CBD19B3-C98D-4EA9-B376-98F79D975C03Q38751931-BCD5C459-6DDA-43A2-AECE-8F30AFBCDE3BQ38783043-C56164E0-1D39-4E8E-8137-1D0701D6D2C8Q39022323-EC9D038D-F681-4144-B82D-F7F9B1E83139Q40155457-8C52DD0A-5B6D-4A30-A2B2-12954405C082Q40361177-15624B91-5EC7-4926-88C9-34B0E86379A3Q51747341-C371EFB3-8684-481B-AABD-C275E1FB80B4Q54999129-5A9F95FC-477C-4A22-BE4C-BF8F62FB7255Q55057062-D3D04794-F29B-4C7E-AC0D-BE4D8601185D
P2860
MEDI4893* Promotes Survival and Extends the Antibiotic Treatment Window in a Staphylococcus aureus Immunocompromised Pneumonia Model
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
MEDI4893* Promotes Survival an ...... unocompromised Pneumonia Model
@ast
MEDI4893* Promotes Survival an ...... unocompromised Pneumonia Model
@en
type
label
MEDI4893* Promotes Survival an ...... unocompromised Pneumonia Model
@ast
MEDI4893* Promotes Survival an ...... unocompromised Pneumonia Model
@en
prefLabel
MEDI4893* Promotes Survival an ...... unocompromised Pneumonia Model
@ast
MEDI4893* Promotes Survival an ...... unocompromised Pneumonia Model
@en
P2093
P2860
P356
P1476
MEDI4893* Promotes Survival an ...... unocompromised Pneumonia Model
@en
P2093
B R Sellman
C K Stover
J J Hilliard
P2860
P304
P356
10.1128/AAC.00510-15
P407
P577
2015-05-18T00:00:00Z